Morningstar
•
Jun 29, 2026
Haleon plc: Haleon Earnings: Weak Consumer Health Pressures Volume, but Bright Spots Still Exist
Summary
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
KD: Raising target price to $11.00
Sep 02, 2026
•
KD
OGN: What does Argus have to say about OGN?
Sep 02, 2026
•
OGN
AVTR: What does Argus have to say about AVTR?
Sep 02, 2026
•
AVTR
ROIV: Lowering target price to $36.00
Sep 02, 2026
•
ROIV
Market Update: MRVL, GSK, MET
Sep 01, 2026
•
MET, GSK, MRVL
